Literature DB >> 28489454

Acquisition and Transmission of Streptococcus pneumoniae Are Facilitated during Rhinovirus Infection in Families with Children.

Sinikka Karppinen1, Johanna Teräsjärvi2, Kari Auranen3,4, Linnea Schuez-Havupalo1, Lotta Siira5, Qiushui He2,6, Matti Waris7, Ville Peltola1.   

Abstract

RATIONALE: Laboratory and clinical evidence suggests synergy between rhinoviruses and Streptococcus pneumoniae in the pathogenesis of respiratory tract infections. However, it is unclear whether rhinoviruses promote pneumococcal acquisition and transmission.
OBJECTIVES: To describe the impact of rhinovirus infection on the acquisition and transmission of pneumococci within families with children.
METHODS: We investigated 29 families with at least two children. The follow-up started at the onset of respiratory infectious symptoms in any family member and consisted of daily symptom diary and nasal swab samples from each participant twice per week for 3 weeks. Swabs were taken by the parents and sent to a study clinic by mail. Rhinoviruses were detected by reverse transcription-polymerase chain reaction and typed by sequencing. Pneumococci were identified by an antigen test and by standard culture methods, serotyping, and whole-genome sequencing. The effect of rhinovirus infection on the rates of pneumococcal acquisition and within-family transmission was estimated from the observed acquisition events and person-times spent uncolonized, using Poisson regression.
MEASUREMENTS AND MAIN RESULTS: Rhinovirus was detected in 38 subjects (30%) at the onset and in 86 subjects (67%) during the follow-up. S. pneumoniae was detected on the first day in 9 (7%) and during follow-up in 38 (30%) subjects. Children with rhinovirus infection had a 4.3-fold rate of pneumococcal acquisition from the community (95% confidence interval, 1.1-15.4) and a 14.8-fold rate of within-family transmission (95% confidence interval, 3.1-69.6) compared with children without rhinovirus infection.
CONCLUSIONS: Rhinovirus infection within families facilitates acquisition and within-family transmission of S. pneumoniae.

Entities:  

Keywords:  Streptococcus pneumoniae; children; respiratory tract infection; rhinovirus; viral–bacterial interaction

Mesh:

Year:  2017        PMID: 28489454     DOI: 10.1164/rccm.201702-0357OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Picornavectors. Viruses That Spread Bacteria.

Authors:  James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 2.  Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia.

Authors:  Shigeo Hanada; Mina Pirzadeh; Kyle Y Carver; Jane C Deng
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

3.  Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.

Authors:  Chiara Chiavenna; Anne M Presanis; Andre Charlett; Simon de Lusignan; Shamez Ladhani; Richard G Pebody; Daniela De Angelis
Journal:  PLoS Med       Date:  2019-06-27       Impact factor: 11.069

4.  Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis.

Authors:  Laura Toivonen; Carlos A Camargo; James E Gern; Yury A Bochkov; Jonathan M Mansbach; Pedro A Piedra; Kohei Hasegawa
Journal:  J Allergy Clin Immunol       Date:  2019-01-14       Impact factor: 10.793

Review 5.  Impact of Rhinovirus Infections in Children.

Authors:  Silvia Vandini; Carlotta Biagi; Maximilian Fischer; Marcello Lanari
Journal:  Viruses       Date:  2019-06-05       Impact factor: 5.048

Review 6.  Cross-talk between immune system and microbiota in COVID-19.

Authors:  Shaghayegh Baradaran Ghavami; Mahsa Pourhamzeh; Maryam Farmani; Shahrbanoo Keshavarz Azizi Raftar; Shabnam Shahrokh; Anastasia Shpichka; Hamid Asadzadeh Aghdaei; Mojdeh Hakemi-Vala; Nikoo Hossein-Khannazer; Peter Timashev; Massoud Vosough
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-11-02       Impact factor: 4.095

7.  Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data.

Authors:  Roy Burstein; Benjamin M Althouse; Amanda Adler; Adam Akullian; Elizabeth Brandstetter; Shari Cho; Anne Emanuels; Kairsten Fay; Luis Gamboa; Peter Han; Kristen Huden; Misja Ilcisin; Mandy Izzo; Michael L Jackson; Ashley E Kim; Louise Kimball; Kirsten Lacombe; Jover Lee; Jennifer K Logue; Julia Rogers; Erin Chung; Thomas R Sibley; Katrina Van Raay; Edward Wenger; Caitlin R Wolf; Michael Boeckh; Helen Chu; Jeff Duchin; Mark Rieder; Jay Shendure; Lea M Starita; Cecile Viboud; Trevor Bedford; Janet A Englund; Michael Famulare
Journal:  medRxiv       Date:  2022-02-06

Review 8.  Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review.

Authors:  Hao Wang; Desiree Anthony; Stavros Selemidis; Ross Vlahos; Steven Bozinovski
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

9.  Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract.

Authors:  Joseph A Lewnard; Katia J Bruxvoort; Heidi Fischer; Vennis X Hong; Lindsay R Grant; Luis Jódar; Bradford D Gessner; Sara Y Tartof
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

10.  Inflammation induced by influenza virus impairs human innate immune control of pneumococcus.

Authors:  Simon P Jochems; Fernando Marcon; Beatriz F Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Stephen B Gordon; Jamie Rylance; Helder I Nakaya; Daniela M Ferreira
Journal:  Nat Immunol       Date:  2018-10-29       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.